Simplex Trading, LLC Xenetic Biosciences, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023
BUY
$0.31 - $0.73 $421 - $993
1,361 New
1,361 $0
Q2 2022

Aug 03, 2022
SELL
$0.6 - $1.14 $8,574 - $16,291
-14,291 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$0.88 - $1.37 $26,277 - $40,909
-29,861 Reduced 67.63%
14,291 $14,000
Q4 2021

Feb 23, 2022
BUY
$1.27 - $2.08 $56,073 - $91,836
44,152 New
44,152 $56,000

About Xenetic Biosciences, Inc.

XBIO Quotes by TradingView
  • Ticker XBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,166,600
  • Market Cap $65.1M
  • Description
  • Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...
More about XBIO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email